Industry: FDA Underestimated Burden of Metrics Reporting

It will take more time and resources to set up and run quality metrics reporting programs than FDA estimated, industry says.

Industry raised a lot of concerns about burden in its comments last month on FDA’s Aug. 24 draft quality metrics guidance document.

The agency’s estimated burden of reporting quality metrics under the program it had proposed was too low, all sectors of...

More from United States

More from North America